当前位置: X-MOL 学术Pediatr. Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection
Pediatric Neurology ( IF 3.8 ) Pub Date : 2022-08-01 , DOI: 10.1016/j.pediatrneurol.2022.07.006
Ruth Camila Púa Torrejón 1 , María Victoria Ordoño Saiz 1 , Elena González Alguacil 1 , Marta Furones García 2 , Verónica Cantarín Extremera 1 , María Luz Ruiz Falcó 1 , Víctor Soto Insuga 1
Affiliation  

Introduction

Anosmia and hypogeusia are frequent symptoms in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adults, but their incidence in children is unknown.

Objective

Describe the incidence and associated characteristics of olfactory and gustatory dysfunction in children with SARS-CoV-2 infection.

Material and methods

Descriptive study carried out by telephone survey of patients aged between five and 18 years with SARS-CoV-2 infection confirmed between March and December, 2020.

Results

Two hundred eighty Spanish patients (female: 42.2%) with a mean age of 10.4 years (±3.54, range: 5 to 17) were analyzed, 22.5% with other diseases (mostly respiratory: 11.8%). The most frequent symptoms were fever (55.36%) and neurological symptoms (45.7%). Forty-four (15.7%) were hospitalized due to the infection, in intensive care unit (ICU): 7.1%. Forty-five patients (16.1%) had anosmia and/or hypogeusia: 32 both, eight with hypogeusia only, and five with exclusively anosmia. The mean symptom duration in days for anosmia was 36.4, and for hypogeusia it was 27.6. Either symptom was the initial manifestation in 15 patients. None had anosmia/hypogeusia with no other symptoms. Anosmia/hypogeusia was related to the presence of respiratory infection, gastroenteritis, chills, odynophagia, myalgia, asthenia, and anorexia, but not severity (hospitalization/ICU admission). Cohabitation with another infected individual was associated with a higher incidence of anosmia/hypogeusia (P = 0.041) and duration of anosmia (P = 0.006). The presence of anosmia/hypogeusia in cohabitants was associated with longer duration of anosmia (P < 0.001).

Conclusions

The incidence of anosmia/hypogeusia in children with SARS-CoV-2 was lower than that reported in adults, although with a longer duration. Although no association was found between anosmia/hypogeusia and greater disease severity, recognition of these symptoms could help identify paucisymptomatic patients.



中文翻译:

SARS-CoV-2 感染儿科患者的嗅觉和味觉功能障碍

介绍

嗅觉减退和味觉减退是成人严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 感染的常见症状,但它们在儿童中的发病率尚不清楚。

客观的

描述 SARS-CoV-2 感染儿童嗅觉和味觉功能障碍的发生率和相关特征。

材料与方法

通过电话调查对 2020 年 3 月至 12 月期间确认感染 SARS-CoV-2 的 5 至 18 岁患者进行的描述性研究。

结果

分析了 280 名平均年龄为 10.4 岁(±3.54,范围:5 至 17 岁)的西班牙患者(女性:42.2%),其中 22.5% 患有其他疾病(主要是呼吸道疾病:11.8%)。最常见的症状是发热(55.36%)和神经系统症状(45.7%)。44 人 (15.7%) 因感染住院,在重症监护病房 (ICU):7.1%。45 名患者 (16.1%) 患有嗅觉缺失和/或味觉减退:32 名患者同时患有嗅觉减退症,8 名患者仅有味觉减退症,5 名患者仅有嗅觉减退症。嗅觉丧失的平均症状持续时间为 36.4 天,味觉减退为 27.6 天。在 15 名患者中,任何一种症状都是最初的表现。没有人有嗅觉减退/味觉减退,没有其他症状。嗅觉减退/味觉减退与呼吸道感染、胃肠炎、寒战、吞咽痛、肌痛、乏力和厌食有关,但不是严重程度(住院/入住 ICU)。与另一个感染者同居与较高的嗅觉丧失/味觉减退发生率相关(P  = 0.041) 和嗅觉丧失的持续时间 ( P  = 0.006)。同居者存在嗅觉减退/味觉减退与嗅觉减退持续时间较长有关 ( P  < 0.001)。

结论

SARS-CoV-2 患儿嗅觉减退/味觉减退的发生率低于成人报告的发生率,但持续时间更长。虽然没有发现嗅觉减退/味觉减退与疾病严重程度之间存在关联,但识别这些症状可能有助于识别无症状患者。

更新日期:2022-08-01
down
wechat
bug